A Germ-Line-Selective Advantage Rather Than an Increased Mutation Rate Can Explain Some Unexpectedly Common Human Disease Mutations

Total Page:16

File Type:pdf, Size:1020Kb

A Germ-Line-Selective Advantage Rather Than an Increased Mutation Rate Can Explain Some Unexpectedly Common Human Disease Mutations A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations Soo-Kyung Choi, Song-Ro Yoon, Peter Calabrese*†, and Norman Arnheim*† Molecular and Computational Biology Program, University of Southern California, 1050 Childs Way, Los Angeles, CA 90089-2910 Edited by James F. Crow, University of Wisconsin, Madison, WI, and approved April 16, 2008 (received for review February 7, 2008) Two nucleotide substitutions in the human FGFR2 gene (C755G or mutation hot-spot model (the nucleotide has a higher-than- C758G) are responsible for virtually all sporadic cases of Apert average chance of undergoing a base substitution) at one of these syndrome. This condition is 100–1,000 times more common than sites (C755G). Positive selection for spermatogonial cells car- genomic mutation frequency data predict. Here, we report on the rying a newly arisen mutation is an alternative explanation (4–6, C758G de novo Apert syndrome mutation. Using data on older 11, 12) for an apparently high nucleotide substitution frequency. donors, we show that spontaneous mutations are not uniformly In our earlier study (6), we were unable to reject the selection distributed throughout normal testes. Instead, we find foci where hypothesis as an explanation for the C755G data. C758G mutation frequencies are 3–4 orders of magnitude greater In this work, we studied the other common de novo Apert than the remaining tissue. We conclude this nucleotide site is not nucleotide substitution (C758G). We examined four individual a mutation hot spot even after accounting for possible Luria– testes from three older individuals and two testes from younger Delbruck ‘‘mutation jackpots.’’ An alternative explanation for such donors. By comparing the data on both the C755G and C758G foci involving positive selection acting on adult self-renewing Ap mutations, we were able to ask whether the two mutations were spermatogonia experiencing the rare mutation could not be re- dependent or independent with respect to their anatomical jected. Further, the two youngest individuals studied (19 and 23 distribution throughout each testis. Overall, our results support years old) had lower mutation frequencies and smaller foci at both the selection hypothesis as an explanation for the high frequency mutation sites compared with the older individuals. This implies of both Apert syndrome mutations for being responsible for the that the mutation frequency of foci increases as adults age, and increased chance of older fathers having an affected child thus selection could explain the paternal age effect for Apert (paternal age effect: refs. 1, 11, 13–15). syndrome and other genetic conditions. Our results, now including the analysis of two mutations in the same set of testes, suggest Results that positive selection can increase the relative frequency of C758G Mutation Distribution in Individual Testes. We studied the premeiotic germ cells carrying such mutations, although individu- spatial distribution of de novo C758G mutations within six testes als who inherit them have reduced fitness. In addition, we com- from donors who do not suffer from Apert syndrome. Four of the pared the anatomical distribution of C758G mutation foci with testes were from older donors. Two of these testes were from one both new and old data on the C755G mutation in the same testis donor (374, age 62) and one testis from each of two additional and found their positions were not correlated with one another. donors (854, 54 years; 59089, 45 years). We also examined two testes from younger individuals: one testis each from donors Apert syndrome ͉ paternal age ͉ positive selection ͉ spermatogonia ͉ testis 60832, 23 years, and 59056, 19 years. Each testis was dissected into 192 pieces (six slices each with he frequency at which human germ-line nucleotide substi- 32 pieces), the DNA extracted and a highly specific single- Ttutions arise in each generation can be measured by analysis molecule PCR assay was used to estimate the number of mutant of sporadic cases of human autosomal dominant or sex-linked molecules in each DNA aliquot (see Methods). A sperm sample diseases (1, 2) or by DNA analysis of sperm (3–5). In a recent taken from the epididymis of each testis was also analyzed for article (6), we described an alternative method to study germ-line C758G mutations. The summary data are shown in Table 1 and mutations by dissecting the whole human testis and measuring Fig. 1 [the total DNA content and mutation frequency of each the mutation frequency at a specific nucleotide site in individual piece for all testes are presented in supporting information (SI) pieces. This procedure allowed us to study the spatial distribution Table S1]. The false-positive frequency of the C758G assay was of mutations in this organ and to compare different models of 3.8 ϫ 10Ϫ7 (based on experiments using 31.6 million control the human mutation process. genomes). Individuals born with Apert syndrome (Online Mendelian Among the three older individuals (374, 854, and 59089), the Inheritance in Man no. 101200) exhibit prematurely fused average mutation frequency per testis ranged from 7.3 ϫ 10Ϫ4 to cranial sutures and fused fingers and toes. Most Apert syndrome 1.0 ϫ 10Ϫ4 (Table 1). Each of the four testes is characterized by cases result from a spontaneous fibroblast growth factor receptor 2 gene (FGFR2) mutation in a normal father’s germ line that is transmitted to his offspring. The birth frequency for sporadic Author contributions: P.C. and N.A. designed research; S.-K.C., S.-R.Y., and P.C. performed cases is between 10Ϫ5 and 10Ϫ6 (7, 8). Surprisingly, Ͼ98% of research; S.-K.C., S.-R.Y., P.C., and N.A. analyzed data; and P.C. and N.A. wrote the paper. Apert syndrome cases arise by transversion mutations at only two The authors declare no conflict of interest. sites (C755G and C758G), and a single copy of either mutation This article is a PNAS Direct Submission. is sufficient to cause the disease. The birth frequency of indi- Freely available online through the PNAS open access option. viduals with new mutations at either of these two nucleotide sites *P.C. and N.A. contributed equally to this work. suggests that the mutation frequency at either site is 100- to †To whom correspondence may be addressed. E-mail: [email protected] or petercal@ 1,000-fold greater than expected based on what is known about usc.edu. transversion mutations since humans and chimpanzees last had This article contains supporting information online at www.pnas.org/cgi/content/full/ a common ancestor (9) and mutation data at many human 0801267105/DCSupplemental. MEDICAL SCIENCES disease loci (10). Our previous study (6) allowed us to reject the © 2008 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0801267105 PNAS ͉ July 22, 2008 ͉ vol. 105 ͉ no. 29 ͉ 10143–10148 Downloaded by guest on September 29, 2021 Table 1. Summary data on six testes Epididymal sperm Testis Frequency range Percentage of all mutation mutation among testis No. pieces containing testis genomes Testis Age frequency frequency pieces 95% of mutants* in those pieces Mutation C758G 374–1 62y 5.6 ϫ 10Ϫ4 7.3 ϫ 10Ϫ4 Ͻ4 ϫ 10Ϫ6–0.043 12 8.2 374–2 62y 3.1 ϫ 10Ϫ6 1.0 ϫ 10Ϫ4 Ͻ4 ϫ 10Ϫ6–0.039 1 0.27 854–2 54y 2.7 ϫ 10Ϫ4 1.2 ϫ 10Ϫ4 Ͻ4 ϫ 10Ϫ6–0.011 7 3.6 59089–1 45y 8.2 ϫ 10Ϫ5 1.1 ϫ 10Ϫ4 Ͻ4 ϫ 10Ϫ6–0.005 6 4.5 60832–1 23y ‡ 6.5 ϫ 10Ϫ7 Ͻ4 ϫ 10Ϫ6–9.0 ϫ 10Ϫ6 27 15.3 59056–1 19y 2.0 ϫ 10Ϫ6 5.8 ϫ 10Ϫ7 Ͻ4 ϫ 10Ϫ6–3.1 ϫ 10Ϫ5 14 9.4 Mutation C755G 374–1† 62y 4.5 ϫ 10Ϫ4 3.8 ϫ 10Ϫ4 Ͻ10Ϫ6–0.027 12 5.7 374–2 † 62y 3.9 ϫ 10Ϫ5 6.7 ϫ 10Ϫ5 Ͻ10Ϫ6–0.007 5 2.6 854–2 † 54y 1.1 ϫ 10Ϫ4 6.8 ϫ 10Ϫ4 Ͻ2 ϫ 10Ϫ6–0.047 7 5.0 59089–1 45y 9.1 ϫ 10Ϫ5 1.6 ϫ 10Ϫ4 Ͻ4 ϫ 10Ϫ6–0.008 10 4.9 60832–1 23y ‡ 9.4 ϫ 10Ϫ7 Ͻ4 ϫ 10Ϫ6–9 ϫ 10Ϫ6 35 20.1 59056–1 19y 3.0 ϫ 10Ϫ6 1.6 ϫ 10Ϫ5 Ͻ4 ϫ 10Ϫ6–0.004 20 17 *Based on a resolution of 192 pieces/testis. †Previously published data (6). ‡Not enough sperm could be collected. a very small number of ‘‘hot’’ pieces with mutation frequencies sperm (found in that testis’s epididymis) is near one, ranging 3–4 orders of magnitude greater than most of the remaining from 0.29 to 1.76 (see Table 1). For two more pairs, this ratio is pieces (Fig. 1). In every case, 95% of the mutant molecules were higher at 5.33 and 6.18. In ref. 6, we reported that the relatively found in no more than 12 (average 6.5) of the 192 pieces high ratio of 6.18 for the C755G mutation in 854-2 could result examined, whereas, according to a random spatial distribution, from a highly viscous material found only in the one epididymis, many more pieces, which together contain 95% of the genomes, possibly contaminating that sperm sample with nongerm-line would have been expected. In many cases, several pieces with DNA; this explanation is now unlikely, because for the same high mutation frequencies appear to form foci adjacent to one testis and epididymal sperm sample, the ratio for mutation another in the same slice or even between slices (Fig.
Recommended publications
  • Advances in Understanding the Genetics of Syndromes Involving Congenital Upper Limb Anomalies
    Review Article Page 1 of 10 Advances in understanding the genetics of syndromes involving congenital upper limb anomalies Liying Sun1#, Yingzhao Huang2,3,4#, Sen Zhao2,3,4, Wenyao Zhong1, Mao Lin2,3,4, Yang Guo1, Yuehan Yin1, Nan Wu2,3,4, Zhihong Wu2,3,5, Wen Tian1 1Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China; 2Beijing Key Laboratory for Genetic Research of Skeletal Deformity, Beijing 100730, China; 3Medical Research Center of Orthopedics, Chinese Academy of Medical Sciences, Beijing 100730, China; 4Department of Orthopedic Surgery, 5Department of Central Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China Contributions: (I) Conception and design: W Tian, N Wu, Z Wu, S Zhong; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: Y Huang; (V) Data analysis and interpretation: L Sun; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Wen Tian. Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China. Email: [email protected]. Abstract: Congenital upper limb anomalies (CULA) are a common birth defect and a significant portion of complicated syndromic anomalies have upper limb involvement. Mostly the mortality of babies with CULA can be attributed to associated anomalies. The cause of the majority of syndromic CULA was unknown until recently. Advances in genetic and genomic technologies have unraveled the genetic basis of many syndromes- associated CULA, while at the same time highlighting the extreme heterogeneity in CULA genetics. Discoveries regarding biological pathways and syndromic CULA provide insights into the limb development and bring a better understanding of the pathogenesis of CULA.
    [Show full text]
  • Blueprint Genetics Craniosynostosis Panel
    Craniosynostosis Panel Test code: MA2901 Is a 38 gene panel that includes assessment of non-coding variants. Is ideal for patients with craniosynostosis. About Craniosynostosis Craniosynostosis is defined as the premature fusion of one or more cranial sutures leading to secondary distortion of skull shape. It may result from a primary defect of ossification (primary craniosynostosis) or, more commonly, from a failure of brain growth (secondary craniosynostosis). Premature closure of the sutures (fibrous joints) causes the pressure inside of the head to increase and the skull or facial bones to change from a normal, symmetrical appearance resulting in skull deformities with a variable presentation. Craniosynostosis may occur in an isolated setting or as part of a syndrome with a variety of inheritance patterns and reccurrence risks. Craniosynostosis occurs in 1/2,200 live births. Availability 4 weeks Gene Set Description Genes in the Craniosynostosis Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ALPL Odontohypophosphatasia, Hypophosphatasia perinatal lethal, AD/AR 78 291 infantile, juvenile and adult forms ALX3 Frontonasal dysplasia type 1 AR 8 8 ALX4 Frontonasal dysplasia type 2, Parietal foramina AD/AR 15 24 BMP4 Microphthalmia, syndromic, Orofacial cleft AD 8 39 CDC45 Meier-Gorlin syndrome 7 AR 10 19 EDNRB Hirschsprung disease, ABCD syndrome, Waardenburg syndrome AD/AR 12 66 EFNB1 Craniofrontonasal dysplasia XL 28 116 ERF Craniosynostosis 4 AD 17 16 ESCO2 SC phocomelia syndrome, Roberts syndrome
    [Show full text]
  • Blueprint Genetics Comprehensive Growth Disorders / Skeletal
    Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel Test code: MA4301 Is a 374 gene panel that includes assessment of non-coding variants. This panel covers the majority of the genes listed in the Nosology 2015 (PMID: 26394607) and all genes in our Malformation category that cause growth retardation, short stature or skeletal dysplasia and is therefore a powerful diagnostic tool. It is ideal for patients suspected to have a syndromic or an isolated growth disorder or a skeletal dysplasia. About Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders This panel covers a broad spectrum of diseases associated with growth retardation, short stature or skeletal dysplasia. Many of these conditions have overlapping features which can make clinical diagnosis a challenge. Genetic diagnostics is therefore the most efficient way to subtype the diseases and enable individualized treatment and management decisions. Moreover, detection of causative mutations establishes the mode of inheritance in the family which is essential for informed genetic counseling. For additional information regarding the conditions tested on this panel, please refer to the National Organization for Rare Disorders and / or GeneReviews. Availability 4 weeks Gene Set Description Genes in the Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ACAN# Spondyloepimetaphyseal dysplasia, aggrecan type, AD/AR 20 56 Spondyloepiphyseal dysplasia, Kimberley
    [Show full text]
  • Blueprint Genetics Comprehensive Skeletal Dysplasias and Disorders
    Comprehensive Skeletal Dysplasias and Disorders Panel Test code: MA3301 Is a 251 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of disorders involving the skeletal system. About Comprehensive Skeletal Dysplasias and Disorders This panel covers a broad spectrum of skeletal disorders including common and rare skeletal dysplasias (eg. achondroplasia, COL2A1 related dysplasias, diastrophic dysplasia, various types of spondylo-metaphyseal dysplasias), various ciliopathies with skeletal involvement (eg. short rib-polydactylies, asphyxiating thoracic dysplasia dysplasias and Ellis-van Creveld syndrome), various subtypes of osteogenesis imperfecta, campomelic dysplasia, slender bone dysplasias, dysplasias with multiple joint dislocations, chondrodysplasia punctata group of disorders, neonatal osteosclerotic dysplasias, osteopetrosis and related disorders, abnormal mineralization group of disorders (eg hypopohosphatasia), osteolysis group of disorders, disorders with disorganized development of skeletal components, overgrowth syndromes with skeletal involvement, craniosynostosis syndromes, dysostoses with predominant craniofacial involvement, dysostoses with predominant vertebral involvement, patellar dysostoses, brachydactylies, some disorders with limb hypoplasia-reduction defects, ectrodactyly with and without other manifestations, polydactyly-syndactyly-triphalangism group of disorders, and disorders with defects in joint formation and synostoses. Availability 4 weeks Gene Set Description
    [Show full text]
  • Pfeiffer Syndrome
    Pfeiffer Syndrome *Mrs.Saranya.S Abstract: Pfeiffer syndrome is a rare genetic disorder characterized by premature fusion of certain skull bones (craniosynostosis) and other birth defects in the hands and feet. There are three subtypes of the syndrome, with Types II and III being the most severe. There is no specific treatment for Pfeiffer syndrome. Treatment is directed at improving the individual's symptoms. Pfeiffer syndrome is associated with mutations (changes) in the FGFR genes.It affects about 1 out of every 100,000 children. Pfeiffer syndrome can be inherited or can occur due to a new mutation, or change, in the involved gene. In cases of severe Pfeiffer syndrome, a new mutation is typically the cause. Key words: Pfeiffer syndrome, craniosynstosis, mutations, birth defect . INTRODUCTION Pfeiffer syndrome is a rare birth Pfeiffer syndrome type I or Classic defect ,affects the shape of a baby’s skull Pfeiffer syndrome: It includes and face.In new born, the top of the skull caraniosynstosis and “midface isn’t one solid piece. It’s actually made up of deficiency” Child with Type I Pfeiffer several bones with special joints between syndrome usually have a normal lifespan them. This allows it to expand so the brain and typical intelligence. has room to grow. Normally, the skull bones Pfeiffer syndrome type II The child come together only after the head reaches it present with cloverleaf-shaped skull due full size. In child with Pfeiffer syndrome, the to extensive fusion of bones as well as plates join together too early. The skull can’t proptosis(abnormal protrusion or expand as the brain grows, which affects the displacement of an eye or other body shape of the head and face.Pfeiffer part) and child has poor prognosis and syndrome is also referred to as severe neurological problems generally acrocephalosyndactyly type V(ACSV), with early death.
    [Show full text]
  • DSD-POI-HH Panel (V4) 29-11-2018 Versie Centrum Voor Medische Genetica Gent (122 Genen)
    H9.1-OP2-B4: Genpanel DSD-POI-HH, v5, document in voege op 03/07/2019 DSD-POI-HH panel (v4) 29-11-2018 versie Centrum voor Medische Genetica Gent (122 genen) Github commit: 053b2b9ab0c87deb7778cc9b1eeb160c044bc9dc Associated phenotype, OMIM phenotype ID, phenotype Gene OMIM gene ID mapping key and inheritance pattern AKR1C2 600450 46XY sex reversal 8, 614279 (3), Autosomal recessive AKR1C4 600451 {46XY sex reversal 8, modifier of}, 614279 (3), Autosomal recessive Persistent Mullerian duct syndrome, type I, 261550 (3), Autosomal AMH 600957 recessive Persistent Mullerian duct syndrome, type II, 261550 (3), Autosomal AMHR2 600956 recessive Hypogonadotropic hypogonadism 1 with or without anosmia ANOS1 300836 (Kallmann syndrome 1), 308700 (3), X-linked recessive Androgen insensitivity, 300068 (3), X-linked recessive; Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X- linked recessive; Hypospadias 1, X-linked, 300633 (3), X-linked AR 313700 recessive; {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant; Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive Epileptic encephalopathy, early infantile, 1, 308350 (3), X-linked recessive; Hydranencephaly with abnormal genitalia, 300215 (3), X- linked; Lissencephaly, X-linked 2, 300215 (3), X-linked; Mental ARX 300382 retardation, X-linked 29 and others, 300419 (3), X-linked recessive; Partington syndrome, 309510 (3), X-linked recessive; Proud syndrome, 300004 (3), X-linked Alpha-thalassemia myelodysplasia syndrome, somatic, 300448
    [Show full text]
  • Essential Genetics 5
    Essential genetics 5 Disease map on chromosomes 例 Gaucher disease 単一遺伝子病 天使病院 Prader-Willi syndrome 隣接遺伝子症候群,欠失が主因となる疾患 臨床遺伝診療室 外木秀文 Trisomy 13 複数の遺伝子の重複によって起こる疾患 挿画 Koromo 遺伝子の座位あるいは欠失等の範囲を示す Copyright (c) 2010 Social Medical Corporation BOKOI All Rights Reserved. Disease map on chromosome 1 Gaucher disease Chromosome 1q21.1 1p36 deletion syndrome deletion syndrome Adrenoleukodystrophy, neonatal Cardiomyopathy, dilated, 1A Zellweger syndrome Charcot-Marie-Tooth disease Emery-Dreifuss muscular Hypercholesterolemia, familial dystrophy Hutchinson-Gilford progeria Ehlers-Danlos syndrome, type VI Muscular dystrophy, limb-girdle type Congenital disorder of Insensitivity to pain, congenital, glycosylation, type Ic with anhidrosis Diamond-Blackfan anemia 6 Charcot-Marie-Tooth disease Dejerine-Sottas syndrome Marshall syndrome Stickler syndrome, type II Chronic granulomatous disease due to deficiency of NCF-2 Alagille syndrome 2 Copyright (c) 2010 Social Medical Corporation BOKOI All Rights Reserved. Disease map on chromosome 2 Epiphyseal dysplasia, multiple Spondyloepimetaphyseal dysplasia Brachydactyly, type D-E, Noonan syndrome Brachydactyly-syndactyly syndrome Peters anomaly Synpolydactyly, type II and V Parkinson disease, familial Leigh syndrome Seizures, benign familial Multiple pterygium syndrome neonatal-infantile Escobar syndrome Ehlers-Danlos syndrome, Brachydactyly, type A1 type I, III, IV Waardenburg syndrome Rhizomelic chondrodysplasia punctata, type 3 Alport syndrome, autosomal recessive Split-hand/foot malformation Crigler-Najjar
    [Show full text]
  • Malformation Syndromes: a Review of Mouse/Human Homology
    J Med Genet: first published as 10.1136/jmg.25.7.480 on 1 July 1988. Downloaded from Joalrn(ll of Medical Genetics 1988, 25, 480-487 Malformation syndromes: a review of mouse/human homology ROBIN M WINTER Fromii the Kennetivdy Galton Centre, Clinlicail Research Centre, Northiwick Park Hospital, Harrow, Middlesex HAI 3UJ. SUMMARY The purpose of this paper is to review the known and possible homologies between mouse and human multiple congenital anomaly syndromes. By identifying single gene defects causing similar developmental abnormalities in mouse and man, comparative gene mapping can be carried out, and if the loci in mouse and man are situated in homologous chromosome segments, further molecular studies can be performed to show that the loci are identical. This paper puts forward tentative homologies in the hope that some will be investigated and shown to be true homologies at the molecular level, thus providing mouse models for complex developmental syndromes. The mouse malformation syndromes are reviewed according to their major gene effects. X linked syndromes are reviewed separately because of the greater ease of establishing homology for these conditions. copyright. The purpose of this paper is to review the known even phenotypic similarity would be no guarantee and possible homologies between mouse and human that such genes in man and mouse are homologous". genetic malformation syndromes. Lalley and By identifying single gene defects causing similar following criteria for developmental abnormalities in mouse and man, McKusick' recommend the http://jmg.bmj.com/ identifying gene homologies between species: comparative gene mapping can be carried out, and if (1) Similar nucleotide or amino acid sequence.
    [Show full text]
  • Discover Dysplasias Gene Panel
    Discover Dysplasias Gene Panel Discover Dysplasias tests 109 genes associated with skeletal dysplasias. This list is gathered from various sources, is not designed to be comprehensive, and is provided for reference only. This list is not medical advice and should not be used to make any diagnosis. Refer to lab reports in connection with potential diagnoses. Some genes below may also be associated with non-skeletal dysplasia disorders; those non-skeletal dysplasia disorders are not included on this list. Skeletal Disorders Tested Gene Condition(s) Inheritance ACP5 Spondyloenchondrodysplasia with immune dysregulation (SED) AR ADAMTS10 Weill-Marchesani syndrome (WMS) AR AGPS Rhizomelic chondrodysplasia punctata type 3 (RCDP) AR ALPL Hypophosphatasia AD/AR ANKH Craniometaphyseal dysplasia (CMD) AD Mucopolysaccharidosis type VI (MPS VI), also known as Maroteaux-Lamy ARSB syndrome AR ARSE Chondrodysplasia punctata XLR Spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMDJL1) B3GALT6 Ehlers-Danlos syndrome progeroid type 2 (EDSP2) AR Multiple joint dislocations, short stature and craniofacial dysmorphism with B3GAT3 or without congenital heart defects (JDSCD) AR Spondyloepimetaphyseal dysplasia (SEMD) Thoracic aortic aneurysm and dissection (TADD), with or without additional BGN features, also known as Meester-Loeys syndrome XL Short stature, facial dysmorphism, and skeletal anomalies with or without BMP2 cardiac anomalies AD Acromesomelic dysplasia AR Brachydactyly type A2 AD BMPR1B Brachydactyly type A1 AD Desbuquois dysplasia CANT1 Multiple epiphyseal dysplasia (MED) AR CDC45 Meier-Gorlin syndrome AR This list is gathered from various sources, is not designed to be comprehensive, and is provided for reference only. This list is not medical advice and should not be used to make any diagnosis.
    [Show full text]
  • Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models
    CHAPTER SEVENTEEN From Bench to Bedside and Back: Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models Alice F. Goodwin*,†, Rebecca Kim*,†, Jeffrey O. Bush*,{,},1, Ophir D. Klein*,†,},},1 *Program in Craniofacial Biology, University of California San Francisco, San Francisco, California, USA †Department of Orofacial Sciences, University of California San Francisco, San Francisco, California, USA { Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, California, USA } Department of Pediatrics, University of California San Francisco, San Francisco, California, USA } Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA 1Corresponding authors: e-mail address: [email protected]; [email protected] Contents 1. Models to Uncover Genetics of Cleft Lip and Palate 460 2. Treacher Collins: Proof of Concept of a Nonsurgical Therapeutic for a Craniofacial Syndrome 467 3. RASopathies: Understanding and Developing Treatment for Syndromes of the RAS Pathway 468 4. Craniosynostosis: Pursuing Genetic and Pharmaceutical Alternatives to Surgical Treatment 473 5. XLHED: Developing Treatment Based on Knowledge Gained from Mouse and Canine Models 477 6. Concluding Thoughts 481 Acknowledgments 481 References 481 Abstract Craniofacial anomalies are among the most common birth defects and are associated with increased mortality and, in many cases, the need for lifelong treatment. Over the past few decades, dramatic advances in the surgical and medical care of these patients have led to marked improvements in patient outcomes. However, none of the treat- ments currently in clinical use address the underlying molecular causes of these disor- ders. Fortunately, the field of craniofacial developmental biology provides a strong foundation for improved diagnosis and for therapies that target the genetic causes # Current Topics in Developmental Biology, Volume 115 2015 Elsevier Inc.
    [Show full text]
  • Date Due Date Due Date Due
    PLACE ll RETURN BOX to roman this chockout from your mood. TO AVOID FINES Mom on or baton dd. duo. DATE DUE DATE DUE DATE DUE MSU In An Affirmative Action/Equal Opponfirmy Inflation mm: SCREENING FOR MUTATIONS IN PAX3 AND MITF IN WAARDENBURG SYNDROME AND WAARDENBURG SYNDROME-LIKE INDIVIDUALS By Melisa Lynn Carey A THESIS Submitted to Michigan State University in partial fulfillment of the requirements for a degree of MASTER OF SCIENCE Department of Zoology 1 996 ABSTRACT SCREENING FOR MUTATIONS IN PAX3 AND MITF IN WAARDENBURG SYNDROME AND WAARDENBURG SYNDROME-LIKE INDIVIDUALS BY Melisa L. Carey Waardenburg Syndrome (WS) is an autosomal dominant disorder characterized by pigmentary and facial anomalies and congenital deafness. Mutations causing WS have been reported in PAX3 and MITF. The goal of this study was to characterize the molecular defects in 33 unrelated WS individuals. Mutation detection was performed using Single Strand Conformational Polymorphism (SSCP) analysis and sequencing methods. Among the 33 WS individuals, a total of eight mutations were identified, seven in PAX3 and one in MITF. In this study, one of the eight mutations was identified and characterized in PAX3 exon seven in a WSI family (UoM1). The proband of UoM1 also has Septo-Optic Dysplasia. In a large family (MSU22) with WS-Iike dysmorphology and additional craniofacial anomalies, linkage was excluded to PAX3 and no mutations were identified in MITF. Herein I review the status of mutation detection in our proband screening set and add to the understanding of the role of PAX3 and MITF in development by exploring new phenotypic characteristics associated with WS.
    [Show full text]
  • IMAGING CASE REPORT Apert Syndrome with Omphalocele
    Journal of Perinatology (2010) 30, 695–697 r 2010 Nature America, Inc. All rights reserved. 0743-8346/10 www.nature.com/jp IMAGING CASE REPORT Apert syndrome with omphalocele TE Herman and MJ Siegel Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA Journal of Perinatology (2010) 30, 695–697; doi:10.1038/jp.2010.72 complete reconstruction at a later date. Because of choanal stenosis a tracheostomy tube was placed and a gastrosotomy tube was Case presentation placed for nutrition. A 2230 g female infant was born after a spontaneous vaginal Apert syndrome was originally described in 1906 by Eugene delivery at 33 weeks gestation to a gravid 1, para 1 38-year-old Apert from the Hopital des Enfant Malades in Paris; in an mother and a 42-year-old father. The pregnancy had been article De l’acrocephalosyndactylie, he created the word complicated by maternal Graves’ disease treated by Synthroid, and acrocephalosyndactyly to describe a condition that now bears by an abnormal fetal sonogram. The sonogram had demonstrated his name. Currently, Apert syndrome is also called an omphalocele. Intrauterine fetal chromosomal analysis acrocephalosyndactyly syndrome type I because subsequently other demonstrated normal chromosomes 46XX. At delivery, the infant similar conditions of digital abnormalities and craniosynostosis was in no respiratory distress but had striking brachycephaly, were described such as Pfeiffer syndrome, Saethre Chotzen proptosis with shallow orbits, low nasal bridge, a cleft soft palate, syndrome and Jackson-Weiss syndrome,1 and considered types of bilateral choanal stenosis and syndactyly of the toes and fingers. acrocephalosyndactyly using Apert’s neologism as a general A large midline omphalocele was also present.
    [Show full text]